The Coronary AccEss After Tavi Registry - A Multicenter Prospective Registry for the Coronary Access After TAVI
NCT ID: NCT04647864
Last Updated: 2021-07-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
600 participants
OBSERVATIONAL
2021-01-28
2022-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post-TAVI Coronary Access Study
NCT04649190
Revascularization After Transcatheter Aortic Valve Implantation (REVIVAL)
NCT03283501
Women's INternational Transcatheter Aortic Valve Implantation Registry
NCT01819181
CGA-TAVI Registry to Evaluate the Predictive Value of a CGA in Predicting TAVI Outcomes
NCT01991444
The Prospective LEUVEN Transcatheter Valve Therapy Registry
NCT03674788
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Edwards Sapien 3 and Edwards Sapien 3 Ultra
Transcatheter Aortic Valve Implantation
Replacement of the aortic valve of the heart through the blood vessels, delivered via one of several access methods.
Group 2
Medtronic Corevalve Evolut R and Medtronic Corevalve Evolut PRO
Transcatheter Aortic Valve Implantation
Replacement of the aortic valve of the heart through the blood vessels, delivered via one of several access methods.
Group 3
Boston Scientific Acurate neo and Boston Scientific Acurate neo2
Transcatheter Aortic Valve Implantation
Replacement of the aortic valve of the heart through the blood vessels, delivered via one of several access methods.
Group 4
St. Jude Medical Portico
Transcatheter Aortic Valve Implantation
Replacement of the aortic valve of the heart through the blood vessels, delivered via one of several access methods.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcatheter Aortic Valve Implantation
Replacement of the aortic valve of the heart through the blood vessels, delivered via one of several access methods.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Provision of signed informed consent;
* Age ≥18 Years.
Exclusion Criteria
* Current participation in an interventional clinical study;
* Age \< 18 years.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondazione GISE Onlus
OTHER
University of Padova
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Azienda Ospedale Università Padova
Padua, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Giuseppe Tarantini
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CAvEAT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.